Multiple Sclerosis
Medical Cannabis supports a variety of symptoms faced by MS patients such as pain, tremor and spasms. In addition, certain strains can support sleep and promote appetite.
We provide professional counseling for treatment and strains to our patients, in a set meeting with one of our registered nurses in our clinic.
 
The Indication by the Israeli Ministry of Health:
Multiple Sclerosis- Patients suffering from spasticity that aren’t responding to conventional treatment options. 
 
Get a License

Research

Cannabinoids in multiple sclerosis (CAMS) study: safety and efficacy data for 12 months follow up

Zajicek JP, Sanders HP, Wight DE, Vickery PJ, Ingram WM, Reilly SM, Nunn AJ, Teare LJ, Fox PJ, Thompson AJ.

J Neurol Neurosurg Psychiatry. 2005 Dec;76(12):1664-9.

https://www.ncbi.nlm.nih.gov/pubmed/16291891


Do cannabis-based medicinal extracts have general or specific effects on symptoms in multiple sclerosis? A double-blind, randomized, placebo-controlled study on 160 patients.

Wade DT, Makela P, Robson P, House H, Bateman C.

Mult Scler. 2004 Aug;10(4):434-41.

Oxford Centre for Enablement, Windmill Road, Oxford OX3 7LD, UK. derick.wade@dsl.pipex.com

https://journals.sagepub.com/doi/10.1191/1352458504ms1082oa


Cannabinoid-induced effects on the nociceptive system: a neurophysiological study in patients with secondary progressive multiple sclerosis.

Conte A, Bettolo CM, Onesti E, Frasca V, Iacovelli E, Gilio F, Giacomelli E, Gabriele M, Aragona M, Tomassini V, Pantano P, Pozzilli C, Inghilleri MEur J Pain. 2009 May;13(5):472-7.

https://onlinelibrary.wiley.com/doi/abs/10.1016/j.ejpain.2008.05.014


The biology that underpins the therapeutic potential of cannabis-based medicines for the control of spasticity in multiple sclerosis

David Baker, Gareth Pryce, Samuel J. Jackson, Chris Bolton, Gavin Giovannoni

https://www.msard-journal.com/article/S2211-0348(11)00035-6/fulltext


Role of cannabinoids in multiple sclerosis
 
Zajicek JP, Apostu VI.
Clinical Neurology Research Group, Peninsula College of Medicine and Dentistry, Plymouth, UK. john.zajicek@phnt.swest.nhs.uk.
 
https://link.springer.com/article/10.2165%2F11539000-000000000-00000
 

 
CANNABIDIOL INHIBITS PATHOGENIC T-CELLS, DECREASES SPINAL MICROGLIAL ACTIVATION AND AMELIORATES MULTIPLE SCLEROSIS-LIKE DISEASE IN C57BL/6 MICE.
 
Kozela E, Lev N, Kaushansky N, Eilam R, Rimmerman N, Levy R, Ben-Nun A, Juknat A, Vogel Z.
The Dr. Miriam and Sheldon G. Adelson Center for the Biology of Addictive Diseases, Physiology and Pharmacology Department, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Neurology Department, Rabin Medical Center, Sackler School of Medicine, Tel Aviv University, Tel Aviv, Israel; Immunology Department, Histology Department, Neurobiology Department, Weizmann Institute of Science, Rehovot, Israel.
https://bpspubs.onlinelibrary.wiley.com/doi/full/10.1111/j.1476-5381.2011.01379.x